Identification of a novel prognostic DNA methylation signature for lung adenocarcinoma based on consensus clustering method

Identification of a novel prognostic DNA methylation signature for lung adenocarcinoma based on consensus clustering method

Abstract Abnormal DNA methylation persists throughout carcinogenesis and cancer development. Hence, gene promoter methylation may act as a prognostic tool and provide new potential therapeutic targets for patients with lung adenocarcinoma (LUAD). In this study, to explore prognostic methylation sign...

Full description

Bibliographic Details
Main Authors:	Qidong Cai, Boxue He, Hui Xie, Pengfei Zhang, Xiong Peng, Yuqian Zhang, Zhenyu Zhao, Xiang Wang
Format:	Article
Language:	English
Published:	Wiley 2020-10-01
Series:	Cancer Medicine
Subjects:	biomarker consensus clustering DNA methylation lung adenocarcinoma
Online Access:	https://doi.org/10.1002/cam4.3343

Similar Items

DNA methylome and transcriptome analysis established a model of four differentially methylated positions (DMPs) as a diagnostic marker in esophageal adenocarcinoma early detection
by: Weilin Peng, et al.
Published: (2021-05-01)

Exploration of predictive and prognostic alternative splicing signatures in lung adenocarcinoma using machine learning methods
by: Qidong Cai, et al.
Published: (2020-12-01)

Identification of four differentially methylated genes as prognostic signatures for stage I lung adenocarcinoma
by: Wei-Ming Luo, et al.
Published: (2018-04-01)

A model of twenty-three metabolic-related genes predicting overall survival for lung adenocarcinoma
by: Zhenyu Zhao, et al.
Published: (2020-09-01)

Construction and validation of a 15-gene ferroptosis signature in lung adenocarcinoma
by: Guangxu Tu, et al.
Published: (2021-07-01)

Comprehensive analysis of gene expression and DNA methylation data identifies potential biomarkers and functional epigenetic modules for lung adenocarcinoma
by: XiaoCong Wang, et al.

Methylation and transcriptome analysis reveal lung adenocarcinoma-specific diagnostic biomarkers
by: Rui Li, et al.
Published: (2019-09-01)

Cell-Free DNA Methylation as Blood-Based Biomarkers for Pancreatic Adenocarcinoma—A Literature Update
by: Stine Dam Henriksen, et al.
Published: (2021-04-01)

EGFR DNA Methylation Correlates With EGFR Expression, Immune Cell Infiltration, and Overall Survival in Lung Adenocarcinoma
by: Zhanyu Xu, et al.
Published: (2021-08-01)

A Novel Prognostic Model of Early-Stage Lung Adenocarcinoma Integrating Methylation and Immune Biomarkers
by: Jin Ren, et al.
Published: (2021-01-01)

A methylation-based nomogram for predicting survival in patients with lung adenocarcinoma
by: Xuelong Wang, et al.
Published: (2021-07-01)

Development and validation of an immune‐related prognostic signature in lung adenocarcinoma
by: Sijin Sun, et al.
Published: (2020-08-01)

The Identification of Critical m6A RNA Methylation Regulators as Malignant Prognosis Factors in Prostate Adenocarcinoma
by: Jiaju Xu, et al.
Published: (2020-12-01)

Identification of prognostic signature in cancer based on DNA methylation interaction network
by: Wei-Lin Hu, et al.
Published: (2017-12-01)

Construction and Comprehensive Analyses of a METTL5-Associated Prognostic Signature With Immune Implication in Lung Adenocarcinomas
by: Sijin Sun, et al.
Published: (2021-02-01)

A Prognostic Signature Constructed by CTHRC1 and LRFN4 in Stomach Adenocarcinoma
by: Songling Han, et al.
Published: (2021-08-01)

Exploration of methylation-driven genes for monitoring and prognosis of patients with lung adenocarcinoma
by: Chundi Gao, et al.
Published: (2018-11-01)

Glycolysis-Related Gene Expression Profiling Screen for Prognostic Risk Signature of Pancreatic Ductal Adenocarcinoma
by: Wenjing Song, et al.
Published: (2021-06-01)

Methylation Regulation of TLR3 on Immune Parameters in Lung Adenocarcinoma
by: Ang Li, et al.
Published: (2021-05-01)

m6A RNA Methylation Regulators Participate in the Malignant Progression and Have Clinical Prognostic Value in Lung Adenocarcinoma
by: Fangwei Li, et al.
Published: (2020-08-01)

Identification of Potential Long Non-coding RNA Expression Quantitative Trait Methylations in Lung Adenocarcinoma and Lung Squamous Carcinoma
by: Xiaohong Wu, et al.
Published: (2020-12-01)

Bioinformatics Analysis of DNA Methylation in the Promoters of LincRNA  in Lung Adenocarcinoma
by: Wen ZHANG, et al.
Published: (2018-06-01)

Identification and validation of novel DNA methylation markers for early diagnosis of lung adenocarcinoma
by: Miao Li, et al.
Published: (2020-11-01)

Specific Glioma Prognostic Subtype Distinctions Based on DNA Methylation Patterns
by: Xueran Chen, et al.
Published: (2019-09-01)

Identification of a four-gene panel predicting overall survival for lung adenocarcinoma
by: Chunyu Li, et al.
Published: (2020-12-01)

A four-DNA methylation signature as a novel prognostic biomarker for survival of patients with gastric cancer
by: Chunmei Li, et al.
Published: (2020-03-01)

Identification of key DNA methylation-driven genes in prostate adenocarcinoma: an integrative analysis of TCGA methylation data
by: Ning Xu, et al.
Published: (2019-09-01)

Identification of the Signature Associated With m6A RNA Methylation Regulators and m6A-Related Genes and Construction of the Risk Score for Prognostication in Early-Stage Lung Adenocarcinoma
by: Bingzhou Guo, et al.
Published: (2021-06-01)

A 13-Gene Metabolic Prognostic Signature Is Associated With Clinical and Immune Features in Stomach Adenocarcinoma
by: Zaisheng Ye, et al.
Published: (2021-06-01)

Identifying a ten-microRNA signature as a superior prognosis biomarker in colon adenocarcinoma
by: Rong Ma, et al.
Published: (2019-12-01)

Plasma Lipidomic Signature of Rectal Adenocarcinoma Reveals Potential Biomarkers
by: Márcia Cristina Fernandes Messias, et al.
Published: (2018-01-01)

Ceramide Pathway Regulators Predict Clinical Prognostic Risk and Affect the Tumor Immune Microenvironment in Lung Adenocarcinoma
by: Yuan Zhang, et al.
Published: (2020-10-01)

Molecular and Clinicopathological Characterization of a Prognostic Immune Gene Signature Associated With MGMT Methylation in Glioblastoma
by: Liang Zhao, et al.
Published: (2021-02-01)

Four-miRNA signature as a prognostic tool for lung adenocarcinoma
by: Lin Y, et al.
Published: (2017-12-01)

Clinical Significance and Immunologic Landscape of a Five-IL(R)-Based Signature in Lung Adenocarcinoma
by: Tao Fan, et al.
Published: (2021-08-01)

Prognostic significance of GAD1 overexpression in patients with resected lung adenocarcinoma
by: Mitsuhiro Tsuboi, et al.
Published: (2019-08-01)

An individualized immune prognostic signature in lung adenocarcinoma
by: Liangdong Sun, et al.
Published: (2020-05-01)

Exploration of Prognostic Biomarkers for Lung Adenocarcinoma Through Bioinformatics Analysis
by: Zhengliang Tu, et al.
Published: (2021-04-01)

The DNA methylation profile of non-coding RNAs improves prognosis prediction for pancreatic adenocarcinoma
by: Jie Zhang, et al.
Published: (2019-04-01)

Clinicopathological significance of DAPK promoter methylation in non-small-cell lung cancer: a systematic review and meta-analysis
by: Zhang Y, et al.
Published: (2018-12-01)